サマリー

市場の分析と洞察。血管閉鎖器具の世界市場
COVID-19の大流行により、血管閉鎖器具の世界市場規模は2021年に10億3688万米ドルの値を示し、2028年には17億3513万米ドルの再調整サイズとなり、予測期間2022-2028年にはCAGR7.74%になると予測されています。
血管閉鎖器具の世界的な主要メーカーは、Abbott Laboratories、Terumo Corporation、Cordis、Morrris Innovative、Teleflex Incorporated、などである。2021年、世界の大手5社は売上高で約93.94％のシェアを占めています。

2021年の北米の血管閉鎖器具の市場規模は4億6,117万米ドル、中国は約1億2,415万米ドルでした。中国の割合は2021年に11.97％で、2028年には19.66％に達し、分析期間を通じてCAGR15.83％をたどると予測されています。ヨーロッパの血管閉鎖器具の状況としては、ドイツは2028年までに8072万米ドルに達すると予測されています。アジアでは、注目すべき市場は日本と韓国で、今後6年間のCAGRはそれぞれ6.57%と6.44%となっています。
COVID-19による経済変化を完全に考慮すると、2021年に血管閉鎖装置の世界市場の20.86％を占めた8Fは、2028年までに3億7687万米ドルの価値を持ち、2022年から2028年まで改訂8.32％のCAGRで成長すると予測されます。インターベンショナルプロシージャセグメントは、この予測期間を通して7.81％のCAGRに変更され、2028年には約89.60％のシェアを持つことになる一方。

血管閉鎖器具の世界的な範囲と市場規模
血管閉鎖器具の世界市場は、地域（国）別、企業別、タイプ別、用途別に分類されています。血管閉鎖器具の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別の売上、収益、2017-2028年までの予測に焦点を当てています。

会社別
アボット・ラボラトリーズ
テルモ株式会社
コルディス
テレフレックス・インコーポレイテッド
モリス・イノベイティブ

タイプ別セグメント
5F
6F
7F
8F
9F
10F
11F
12F
13F
14F
15F
16F
17F
18F
19F
20F
21F
その他

用途別セグメント
血管造影手術
インターベンショナルプロシージャ

地域別
北米
米国
カナダ

アジア太平洋地域
中国
日本
韓国
インド
台湾
東南アジア
オーストラリア

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア

ラテンアメリカ
メキシコ
ブラジル
アルゼンチン

中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 VASCULAR CLOSURE DEVICES MARKET OVERVIEW 1
1.1 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 1
1.2 VASCULAR CLOSURE DEVICES MARKET SEGMENT BY TYPE 4
1.2.1 5F 4
1.2.2 6F 4
1.2.3 7F 5
1.2.4 8F 6
1.2.5 9F 7
1.2.6 10F 8
1.2.7 11F 9
1.2.8 12F 10
1.2.9 13F 11
1.2.10 14F 12
1.2.11 15F 13
1.2.12 16F 14
1.2.13 17F 15
1.2.14 18F 16
1.2.15 19F 17
1.2.16 20F 18
1.2.17 21F 19
1.2.18 OTHERS 20
1.3 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE BY TYPE 21
1.3.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE OVERVIEW BY TYPE (2017-2028) 21
1.3.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022) 23
1.3.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY TYPE (2023-2028) 26
1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE 29
1.4.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022) 29
1.4.2 EUROPE VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022) 32
1.4.3 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022) 35
1.4.4 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022) 38
1.4.5 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY TYPE (2017-2022) 41
2 VASCULAR CLOSURE DEVICES MARKET COMPETITION BY COMPANY 45
2.1 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES SALES (2019-2022) 45
2.2 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES REVENUE (2019-2022) 46
2.3 GLOBAL TOP PLAYERS BY VASCULAR CLOSURE DEVICES PRICE (2019-2022) 46
2.4 GLOBAL TOP MANUFACTURERS VASCULAR CLOSURE DEVICES HEADQUARTERS, SALES AREA 47
2.5 VASCULAR CLOSURE DEVICES MARKET COMPETITIVE SITUATION AND TRENDS 47
2.5.1 VASCULAR CLOSURE DEVICES MARKET CONCENTRATION RATE (2019-2022) 47
2.5.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY VASCULAR CLOSURE DEVICES REVENUE IN 2021 48
2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN VASCULAR CLOSURE DEVICES AS OF 2021) 48
2.7 ESTABLISHED DATE OF KEY VASCULAR CLOSURE DEVICES MANUFACTURERS 49
2.8 KEY MANUFACTURERS VASCULAR CLOSURE DEVICES PRODUCT OFFERED 50
2.9 MERGERS & ACQUISITIONS, EXPANSION 50
3 VASCULAR CLOSURE DEVICES STATUS AND OUTLOOK BY REGION 52
3.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028 52
3.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY REGION 52
3.2.1 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2017-2022) 52
3.2.2 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2017-2022) 53
3.2.3 GLOBAL VASCULAR CLOSURE DEVICES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022) 54
3.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY REGION 54
3.3.1 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2023-2028) 54
3.3.2 GLOBAL VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2023-2028) 55
3.3.3 GLOBAL VASCULAR CLOSURE DEVICES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028) 55
4 VASCULAR CLOSURE DEVICES BY APPLICATION 56
4.1 VASCULAR CLOSURE DEVICES MARKET SEGMENT BY APPLICATION 56
4.1.1 ANGIOGRAPHY SURGERY 56
4.1.2 INTERVENTIONAL PROCEDURES 57
4.2 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE BY APPLICATION 58
4.2.1 GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028) 59
4.2.2 GLOBAL VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022) 60
4.2.3 GLOBAL VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 61
4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION 63
4.3.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022) 63
4.3.2 EUROPE VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022) 64
4.3.3 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022) 64
4.3.4 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022) 65
4.3.5 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES BREAKDOWN BY APPLICATION (2017-2022) 66
5 NORTH AMERICA VASCULAR CLOSURE DEVICES BY COUNTRY 68
5.1 NORTH AMERICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY 68
5.1.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022) 68
5.1.2 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022) 68
5.2 NORTH AMERICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY 69
5.2.1 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028) 69
5.2.2 NORTH AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028) 69
6 EUROPE VASCULAR CLOSURE DEVICES BY COUNTRY 70
6.1 EUROPE VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY 70
6.1.1 EUROPE VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022) 70
6.1.2 EUROPE VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022) 70
6.2 EUROPE VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY 71
6.2.1 EUROPE VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028) 71
6.2.2 EUROPE VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028) 72
7 ASIA-PACIFIC VASCULAR CLOSURE DEVICES BY REGION 73
7.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY REGION 73
7.1.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2017-2022) 73
7.1.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2017-2022) 73
7.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY REGION 74
7.2.1 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VOLUME BY REGION (2023-2028) 74
7.2.2 ASIA-PACIFIC VASCULAR CLOSURE DEVICES SALES IN VALUE BY REGION (2023-2028) 75
8 LATIN AMERICA VASCULAR CLOSURE DEVICES BY COUNTRY 77
8.1 LATIN AMERICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY 77
8.1.1 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022) 77
8.1.2 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022) 77
8.2 LATIN AMERICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY 78
8.2.1 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028) 78
8.2.2 LATIN AMERICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028) 78
9 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES BY COUNTRY 80
9.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES HISTORIC MARKET SIZE BY COUNTRY 80
9.1.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2017-2022) 80
9.1.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2017-2022) 80
9.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES FORECASTED MARKET SIZE BY COUNTRY 81
9.2.1 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VOLUME BY COUNTRY (2023-2028) 81
9.2.2 MIDDLE EAST AND AFRICA VASCULAR CLOSURE DEVICES SALES IN VALUE BY COUNTRY (2023-2028) 82
10 COMPANY PROFILES AND KEY FIGURES IN VASCULAR CLOSURE DEVICES BUSINESS 83
10.1 ABBOTT LABORATORIES 83
10.1.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS 83
10.1.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 84
10.1.3 ABBOTT LABORATORIES VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022) 84
10.1.4 MAIN BUSINESS/BUSINESS OVERVIEW 85
10.2 TERUMO CORPORATION 85
10.2.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS 85
10.2.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 86
10.2.3 TERUMO CORPORATION VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022) 86
10.2.4 MAIN BUSINESS/BUSINESS OVERVIEW 87
10.3 CORDIS 87
10.3.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS 87
10.3.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 88
10.3.3 CORDIS VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022) 89
10.3.4 MAIN BUSINESS/BUSINESS OVERVIEW 89
10.4 TELEFLEX INCORPORATED 89
10.4.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS 89
10.4.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 90
10.4.3 TELEFLEX INCORPORATED VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022) 90
10.4.4 MAIN BUSINESS/BUSINESS OVERVIEW 91
10.5 MORRRIS INNOVATIVE 91
10.5.1 COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS 91
10.5.2 VASCULAR CLOSURE DEVICES PRODUCT OVERVIEW 92
10.5.3 MORRRIS INNOVATIVE VASCULAR CLOSURE DEVICES SALES (K UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (%) (2019-2022) 93
10.5.4 MAIN BUSINESS/BUSINESS OVERVIEW 93
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 94
11.1 VASCULAR CLOSURE DEVICES KEY RAW MATERIALS 94
11.1.1 KEY RAW MATERIALS 94
11.1.2 RAW MATERIALS KEY SUPPLIERS 94
11.2 MANUFACTURING COST STRUCTURE 94
11.2.1 RAW MATERIALS 95
11.2.2 LABOR COST 95
11.2.3 MANUFACTURING EXPENSES 95
11.3 VASCULAR CLOSURE DEVICES INDUSTRIAL CHAIN ANALYSIS 96
11.4 VASCULAR CLOSURE DEVICES MARKET DYNAMICS 96
11.4.1 VASCULAR CLOSURE DEVICES INDUSTRY TRENDS 96
11.4.2 VASCULAR CLOSURE DEVICES MARKET DRIVERS 97
11.4.3 VASCULAR CLOSURE DEVICES MARKET CHALLENGES 97
11.4.4 PORTER'S FIVE FORCES ANALYSIS 97
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 99
12.1 SALES CHANNEL 99
12.2 VASCULAR CLOSURE DEVICES DISTRIBUTORS 100
12.3 VASCULAR CLOSURE DEVICES DOWNSTREAM CUSTOMERS 101
13 RESEARCH FINDINGS AND CONCLUSION 102
14 APPENDIX 103
14.1 RESEARCH METHODOLOGY 103
14.1.1 METHODOLOGY/RESEARCH APPROACH 103
14.1.2 DATA SOURCE 106
14.2 AUTHOR DETAILS 109
14.3 DISCLAIMER 109